Cargando…

Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

Chronic lymphocytic leukemia (CLL) is a B-cell malignancy mainly occurring at an advanced age with no single major genetic driver. Transgenic expression of TCL1 in B cells leads after a long latency to a CLL-like disease in aged Eµ-TCL1 mice suggesting that TCL1 overexpression is not sufficient for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Öztürk, Selcen, Paul, Yashna, Afzal, Saira, Gil-Farina, Irene, Jauch, Anna, Bruch, Peter-Martin, Kalter, Verena, Hanna, Bola, Arseni, Lavinia, Roessner, Philipp M., Schmidt, Manfred, Stilgenbauer, Stephan, Dietrich, Sascha, Lichter, Peter, Zapatka, Marc, Seiffert, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807396/ https://www.ncbi.nlm.nih.gov/pubmed/34417556 http://dx.doi.org/10.1038/s41375-021-01381-4

Ejemplares similares

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy
por: Zapatka, Marc, et al.
Publicado: (2021)

IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
por: Öztürk, Selcen, et al.
Publicado: (2021)

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice
por: Hanna, Bola S., et al.
Publicado: (2020)

Dissecting the Prognostic Significance and Functional Role of Progranulin in Chronic Lymphocytic Leukemia
por: Schulze-Edinghausen, Lena, et al.
Publicado: (2019)

EOMES is essential for antitumor activity of CD8(+) T cells in chronic lymphocytic leukemia
por: Llaó-Cid, Laura, et al.
Publicado: (2021)

EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4(+) T cells in chronic lymphocytic leukemia
por: Roessner, Philipp M., et al.
Publicado: (2021)

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin
por: Dürr, Claudia, et al.
Publicado: (2018)

Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia
por: Faehling, Sebastian, et al.
Publicado: (2023)

CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation
por: Rogers, Michael A., et al.
Publicado: (2015)

Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP
por: Meier, Jan, et al.
Publicado: (2013)

Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021)

Targeted therapy in CLL: changing the treatment paradigm
por: Schneider, Christof, et al.
Publicado: (2019)

From Biology to Therapy: The CLL Success Story
por: Yosifov, Deyan Y., et al.
Publicado: (2019)

Clonal expansion in B-CLL: Fungal drivers or self-service?
por: Greaves, Mel
Publicado: (2013)

Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL
por: Wierzbinska, Justyna A., et al.
Publicado: (2020)

scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis
por: Wong, John K. L., et al.
Publicado: (2023)

Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology
por: Colling, Richard, et al.
Publicado: (2016)

To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?
por: Urbanek, Karol D., et al.
Publicado: (2022)

Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression
por: Arseni, Lavinia, et al.
Publicado: (2023)

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
por: Bruch, Peter‐Martin, et al.
Publicado: (2022)

Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair
por: Sigismondo, Gianluca, et al.
Publicado: (2023)

confFuse: High-Confidence Fusion Gene Detection across Tumor Entities
por: Huang, Zhiqin, et al.
Publicado: (2017)

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL
por: Kadkol, Shrihari S., et al.
Publicado: (2021)

P607: INTEGRATING MULTI-OMICS TO REVEAL THE CLONAL EVOLUTIONARY CHARACTERISTICS IN CLL PATIENTS WITH ZANUBRUTINIB RESISTANCE
por: Zhu, Huayuan, et al.
Publicado: (2023)

Capture and Amplification by Tailing and Switching (CATS): An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA
por: Turchinovich, Andrey, et al.
Publicado: (2014)

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
por: von Tresckow, Julia, et al.
Publicado: (2022)

Mutations driving CLL and their evolution in progression and relapse
por: Landau, Dan A., et al.
Publicado: (2015)

Studies of Myc super-competition and clonal growth in Drosophila males and females
por: Svoysky, Abigail J, et al.
Publicado: (2021)

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
por: Malcikova, Jitka, et al.
Publicado: (2021)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

A novel cloning strategy for one-step assembly of multiplex CRISPR vectors
por: Zuckermann, Marc, et al.
Publicado: (2018)

Atypical rearrangement involving 3′-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression
por: Amarillo, Ina, et al.
Publicado: (2013)

Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL
por: Largeot, Anne, et al.
Publicado: (2023)

Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
por: Siddiqi, Tanya, et al.
Publicado: (2022)

Leptomeningeal involvement in CLL
por: Chantepie, Sylvain P., et al.
Publicado: (2014)

Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
por: Ratnaparkhe, Manasi, et al.
Publicado: (2018)

DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapy
por: Yosifov, Deyan Yordanov, et al.
Publicado: (2020)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Poster: CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fdmrrjvd145usau2ksvgci6q7j